United Kingdom Pharmaceuticals

Shield Therapeutics PLC (STX)

Track

Track

Ticker: STX Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Shield Therapeutics PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hans Peter Hasler Chairman Director
Transaction date
Purchase
Price
412.74
Quantity 78,591
Value £4,433,069
Gregory Madison Chief Executive Officer Officer
Transaction date
Sale
Price
461.30
Quantity 10,726
Value £3,173,746
Hans Peter Hasler Non-Executive Chairman Director
Transaction date
Purchase
Price
467.67
Quantity 52,046
Value £4,068,514
Carmen Hasler Non-Executive Chairman Director
Through Hans Peter Hasler, a closely affiliated person
Transaction date
Purchase
Price
0.37
Quantity 200,000
Value £74,750
Hans Peter Hasler Chairman Director
Transaction date
Purchase
Price
0.59
Quantity 100,000
Value £59,000
Tim Watts Chief Executive Officer Officer
Transaction date
Purchase
Price
0.60
Quantity 100,000
Value £60,250
Tim Watts Chief Executive Officer Officer
Transaction date
Purchase
Price
0.70
Quantity 100,000
Value £69,750
James Karis Chairman Director
Transaction date
Purchase
Price
1.78
Quantity 75,000
Value £133,500
Julie Karen Sampson PCA
Transaction date
Purchase
Price
0.91
Quantity 22,042
Value £19,992
Mark Raymond Sampson Chief Medical Officer Officer
Transaction date
Purchase
Price
0.87
Quantity 22,875
Value £19,993
James Karis Chairman Director
Transaction date
Purchase
Price
0.81
Quantity 50,000
Value £40,730
Carl Sterritt CEO and Director Executive Director
Transaction date
Purchase
Price
0.34
Quantity 88,235
Value £30,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-27 2023-11-21 B Purchase Hans Peter Hasler

Chairman

Director
78,591
412.74
£4,433,069 		78,591 412.74 £4,433,069
2022-12-28 2022-12-23 S Sale Gregory Madison

Chief Executive Officer

Officer
10,726
461.30
£3,173,746 		10,726 461.30 £3,173,746
2021-03-05 2021-03-05 B Purchase Hans Peter Hasler

Non-Executive Chairman

Director
52,046
467.67
£4,068,514 		52,046 467.67 £4,068,514
2021-03-04 2021-03-03 B Purchase Carmen Hasler

Non-Executive Chairman

Through Hans Peter Hasler, a closely affiliated person Director
200,000
0.37
£74,750 		200,000 0.37 £74,750
2021-01-21 2021-01-20 B Purchase Hans Peter Hasler

Chairman

Director
100,000
0.59
£59,000 		100,000 0.59 £59,000
2021-01-19 2021-01-19 B Purchase Tim Watts

Chief Executive Officer

Officer
100,000
0.60
£60,250 		100,000 0.60 £60,250
2020-12-14 2020-12-11 B Purchase Tim Watts

Chief Executive Officer

Officer
100,000
0.70
£69,750 		100,000 0.70 £69,750
2019-08-15 2019-08-13 B Purchase James Karis

Chairman

Director
75,000
1.78
£133,500 		75,000 1.78 £133,500
2019-04-26 2019-04-25 B Purchase Julie Karen Sampson

PCA
22,042
0.91
£19,992 		22,042 0.91 £19,992
2019-04-26 2019-04-25 B Purchase Mark Raymond Sampson

Chief Medical Officer

Officer
22,875
0.87
£19,993 		22,875 0.87 £19,993
2019-04-17 2019-04-16 B Purchase James Karis

Chairman

Director
50,000
0.81
£40,730 		50,000 0.81 £40,730
2018-09-24 2018-09-21 B Purchase Carl Sterritt

CEO and Director

Executive Director
88,235
0.34
£30,000 		88,235 0.34 £30,000
Explore more

More insider trading research around Shield Therapeutics PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe